Stocktoria
PLIANT THERAPEUTICS, INC. PLRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-06-03
PLIANT THERAPEUTICS, INC. statistics & valuation
Market cap$70.6M
P / B0.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | -11654.7% | -1313.4% | -1288.1% |
| Net margin | — | — | -10211.1% | -1273.3% | -1284.5% |
| FCF margin | — | — | -7422.9% | -995.3% | -1022.1% |
| Return on assets | -66.3% | -53.0% | -31.5% | -35.2% | -44.0% |
| Return on equity | -82.4% | -69.2% | -34.1% | -39.4% | -48.9% |
| Debt / equity | 0.00× | 0.10× | 0.02× | 0.03× | 0.00× |
| Current ratio | 12.00 | 10.91 | 17.72 | 14.23 | 12.44 |
| Revenue growth | — | -100.0% | -83.7% | 27.9% | -81.9% |
Source: SEC EDGAR filings · CIK 0001746473 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.